Academia
Unlocking the potential of patient data using healthcare data standards
May 24, 2023 · Janssen Pharmaceutica
University Hospital Ghent and VIB are testing medication to treat COVID-19-associated respiratory illness
University Hospital Ghent and VIB are assessing a drug called Leukine® to treat patients with respiratory illness associated with COVID-19. Major medical centers in [...] March 25, 2020 · BioVox
Belgian clinical trials for COVID-19
With COVID-19 cases soaring into the millions, and a vaccine still a ways off, patients are desperate for a treatment. […] May 5, 2020 · BioVox
Talking T cells with David Masopust
Immunology is a complex but vitally important branch of the life sciences. Earlier this year, we attended a Keystone Symposia […] June 8, 2020 · BioVox
Fundamental research leads to treatment breakthrough in rare genetic diseases
A basic research breakthrough is improving patient lives, as researchers realized their rare genetic condition could be treated by repurposing […] June 8, 2020 · BioVox
Colorectal cancer discovery raises hope for microbiome treatment
A new mechanism causing colorectal cancer has been discovered by researchers from VIB and Ghent University. A specific protein was […] July 7, 2020 · BioVox
VIB: the driving force behind a booming biotech ecosystem
Since VIB was established, the world class research institute has been led by a duo of managing directors. As Johan […] July 7, 2020 · BioVox
UAntwerp researchers find cause for mysterious nodding syndrome
For decades, researchers have been trying to uncover the cause of nodding syndrome, a mysterious and deadly form of epilepsy […] September 30, 2020 · BioVox
Get to know Lewis Cantley: winner of the 2020 Dr. Paul Janssen Award
Every year, the Dr. Paul Janssen Award for Biomedical Research is granted to a scientist who embodies the eponymous man’s […] September 30, 2020 · Janssen Pharmaceutica
The rapid evolution of Chinese biotech
The world is smaller today than it has ever been. With the COVID-19 pandemic, we have seen the advantages of […] December 2, 2020 · Turnstone Communications
Prestigious prize for Belgian breakthrough in brain research
Prof. Dr. Pierre Vanderhaeghen from VIB-KU Leuven has been awarded the Generet Prize for Rare Diseases for his research on […] January 27, 2021 · BioVox
V-Bio Ventures: a fresh fund with a difference
V-Bio Ventures recently announced their second fund, with the first closing already totaling 78 million euros [final close at 110 […] February 24, 2021 · V-Bio Ventures
Record-breaking pollen levels linked to increased risk of COVID-19
Increased pollen concentrations are correlated with higher rates of COVID-19. Hot on the heels of record-breaking European pollen counts, this […] March 10, 2021 · BioVox